Enlivex Therapeutics
(NASDAQ) ENLV
Enlivex Therapeutics Financials at a Glance
Market Cap
$225.42M
Revenue (TTM)
$0.00
Net Income (TTM)
$1.24B
EPS (TTM)
$25.48
P/E Ratio
0.04
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$0.92
Volume
0
Open
$0.92
Price
$0.92
Volume
0
Open
$0.92
Previous Close
$0.92
Daily Range
$0.91 - $0.94
52-Week Range
$0.66 - $2.10
Dividend
$0.00
Beta (Volatility)
0.84 (Low)
Price
$0.92
Volume
0
Open
$0.92
Previous Close
$0.92
Daily Range
$0.91 - $0.94
52-Week Range
$0.66 - $2.10
ENLV News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Enlivex Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
34
CEO
Oren Hershkovitz, PhD
Website
www.enlivex.comHeadquarters
Ness Ziona, 7403618, IL
ENLV Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
126%
Return on Capital
-1%
Return on Assets
53%
Earnings Yield
25.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$225.42M
Shares Outstanding
237.38M
Volume
0
Short Interest
0.00%
Avg. Volume
560.01K
Financials (TTM)
Gross Profit
$332.00K
Operating Income
$15.00M
EBITDA
$14.67M
Operating Cash Flow
$10.42M
Capital Expenditure
$68.00K
Free Cash Flow
$10.48M
Cash & ST Invst.
$5.87M
Total Debt
$641.00K
Enlivex Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$76.00K
-111.1%
Gross Margin
0.00%
N/A
Market Cap
$225.42M
N/A
Market Cap/Employee
$3.17M
N/A
Employees
71
N/A
Net Income
$1.24B
+24115.7%
EBITDA
$5.79M
-12.5%
Quarterly Fundamentals
Net Cash
$5.23M
-77.3%
Accounts Receivable
$235.00K
-82.0%
Inventory
$0.00
N/A
Long Term Debt
$383.00K
+28.1%
Short Term Debt
$258.00K
+9.8%
Return on Assets
53.10%
N/A
Return on Invested Capital
-0.65%
N/A
Free Cash Flow
$2.91M
+29.9%
Operating Cash Flow
$2.90M
+29.5%